Hodgkin's lymphoma. II: Treatment and delayed morbidity.
作者信息
Carde P
机构信息
Service de Médecine, CS Axel Unit, Institut Gustave-Roussy, Villejuif, France.
出版信息
BMJ. 1992 Jul 18;305(6846):173-6. doi: 10.1136/bmj.305.6846.173.
Abstract
摘要
相似文献
1
Hodgkin's lymphoma. II: Treatment and delayed morbidity.霍奇金淋巴瘤。II：治疗与迟发性发病
BMJ. 1992 Jul 18;305(6846):173-6. doi: 10.1136/bmj.305.6846.173.
2
Evolution of the concept of prognostication in therapy of Hodgkin's lymphoma.霍奇金淋巴瘤治疗中预后判断概念的演变
Leuk Lymphoma. 1995;15 Suppl 1:15-8. doi: 10.3109/10428199509052698.
3
Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.高剂量环磷酰胺、依托泊苷和顺铂序贯自体骨髓或外周血干细胞移植治疗预后不良的霍奇金淋巴瘤或非霍奇金淋巴瘤的I/II期研究
Bone Marrow Transplant. 1993 Oct;12(4):337-45.
4
Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease.
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):525-8. doi: 10.1016/0360-3016(95)02071-I.
5
[Autologous bone marrow transplantation in Hodgkin's disease].[霍奇金病的自体骨髓移植]
Dtsch Med Wochenschr. 1987 Feb 20;112(8):314-20. doi: 10.1055/s-2008-1068051.
6
[Therapy of recurrent Hodgkin's lymphoma. II. The value of bone marrow transplantation].复发性霍奇金淋巴瘤的治疗。II. 骨髓移植的价值
Dtsch Med Wochenschr. 1989 Jun 9;114(23):916-21. doi: 10.1055/s-2007-1024466.
7
Role of chemoresistance prior to autologous bone marrow transplantation for Hodgkin's disease.自体骨髓移植前化疗耐药在霍奇金淋巴瘤中的作用。
Nouv Rev Fr Hematol (1978). 1994 Dec;36(6):423-30.
8
Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.外周血祖细胞与骨髓作为非霍奇金淋巴瘤和霍奇金病患者大剂量化疗造血支持的随机试验：临床与分子分析
Bone Marrow Transplant. 1999 Sep;24(5):473-81. doi: 10.1038/sj.bmt.1701941.
9
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.分割全身照射、依托泊苷和环磷酰胺联合自体移植治疗霍奇金淋巴瘤和非霍奇金淋巴瘤。
J Clin Oncol. 1994 Dec;12(12):2552-8. doi: 10.1200/JCO.1994.12.12.2552.
10
Indications for high-dose therapy with hematopoietic support in patients with Hodgkin's disease.霍奇金病患者采用造血支持的大剂量治疗指征。
Leukemia. 1993 Jul;7(7):1087-90.
引用本文的文献
1
Treatment of Hodgkin's lymphoma.霍奇金淋巴瘤的治疗
BMJ. 1992 Aug 8;305(6849):367. doi: 10.1136/bmj.305.6849.367-a.
本文引用的文献
1
A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.用MOPP化疗治疗霍奇金病的剂量和时间反应分析。
J Clin Oncol. 1983 Feb;1(2):146-53. doi: 10.1200/JCO.1983.1.2.146.
2
The prognostic significance of large mediastinal masses in the treatment of Hodgkin's disease. The experience of the Institut Gustave-Roussy.纵隔大肿块在霍奇金病治疗中的预后意义。古斯塔夫-鲁西研究所的经验。
Hematol Oncol. 1984 Jan-Mar;2(1):33-43. doi: 10.1002/hon.2900020105.
3
Single agent palliative chemotherapy for end-stage Hodgkin's disease.晚期霍奇金淋巴瘤的单药姑息化疗
Cancer. 1982 Sep 1;50(5):829-35. doi: 10.1002/1097-0142(19820901)50:5<829::aid-cncr2820500504>3.0.co;2-r.
4
Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.
Ann Intern Med. 1982 Feb;96(2):139-43. doi: 10.7326/0003-4819-96-2-139.
5
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease.大剂量环磷酰胺、卡莫司汀和依托泊苷及自体骨髓移植治疗复发性霍奇金淋巴瘤。
Ann Intern Med. 1986 Feb;104(2):163-8. doi: 10.7326/0003-4819-104-2-163.
6
Risk of second cancers after treatment for Hodgkin's disease.霍奇金淋巴瘤治疗后发生二次癌症的风险。
N Engl J Med. 1988 Jan 14;318(2):76-81. doi: 10.1056/NEJM198801143180203.
7
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease.
J Natl Cancer Inst. 1988 Nov 16;80(18):1466-73. doi: 10.1093/jnci/80.18.1466.
8
Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.ⅠA期和ⅡA期膈上型霍奇金淋巴瘤：接受斗篷野和主动脉旁照射的手术分期患者的预后因素
J Clin Oncol. 1988 Oct;6(10):1576-83. doi: 10.1200/JCO.1988.6.10.1576.
9
Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.仅用MOPP或ChlVPP化疗方案治疗各期儿童霍奇金病。
J Clin Oncol. 1988 Dec;6(12):1845-50. doi: 10.1200/JCO.1988.6.12.1845.
10
Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index.
Lancet. 1985 Apr 27;1(8435):967-72. doi: 10.1016/s0140-6736(85)91736-2.
Zotero 插件